Read more about the FDA approval here: fda.gov/drugs/drug-approval...
This is the second drug approved for MET exon 14 skipping alterations. If you have any questions about this treatment or others, feel free to email us at support@go2foundation.org
FDA grants accelerated approval for te... - Lung Cancer Support
FDA grants accelerated approval for tepotinib for metastatic non-small cell lung cancer with MET exon 14 skipping alterations
Miranda_GO2Partner
Written by
Miranda_GO2
Partner
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
FDA approval for Investigational drug Small Cell Lung Cancer
Hello all,
FDA approved APG-1252 as a investigational drug for treatment for small cell on or about...
Opdivo and Yervoy combination approved for Non-small cell lung cancer
More exciting approval announcements for this week.
On May 15th, 2020, the Food and Drug...
First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)
On December 18th, 2020, the Food and Drug Administration (FDA) approved Tagrisso (osimertinib) for...
Devastated! my Non-Small Cell Lung Cancer Transformed into Small Cell Lung Cancer
Hello Friends, It has been a while since I posted. I was originally diagnosed 7 1/2 months ago...
Mutation testing for small cell lung cancer Stage 4
Hello all
I meet with my Doctors on the 17 Jan 17. I want to push the testing of mutations with...
Related Posts
- FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression
Staying positive and hopeful for my dad with small cell lung cancer
Trying to remain optimistic for my Dad with Small Cell Lung Cancer.. any advice is welcome.
Update
An immunotherapy now approved for first-line treatment
